Paolo Ciracì: Liquid biopsy to guide adjuvant treatment choice in CRC

Paolo Ciracì, Oncology Resident at University Hospital of Pisa, shared on X/Twitter:

“Liquid biopsy to guide adjuvant treatment (tx) choice in CRC.

Our review on ongoing trials investigating:
treatment intensification in ctDNA + patients
treatment de-escalation in ctDNA – patients
post-adjuvant treatment in ctDNA + patients.”

Visit the article website.
Source: Paolo Ciracì/X

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”